2013-02-06 14:10:19 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Pani Teresa Medica SA and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering Pani Teresa Medica SA (TER). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Pani Teresa Medica SA investor.
Report Summary: Pani Teresa Medica SA is an above average quality company with a neutral outlook. Pani Teresa Medica SA has medium business growth and is run by efficient management. The trend in Pani Teresa Medica SA fair value exchange rate against its closest rated-competitor, EMC Instytut Medyczny SA, has been depreciating over the past 2 weeks. When compared to its closest competitor, Pani Teresa Medica SA shows less undervaluation and is equally likely to outperform the market.
The 3-page report
breaks down the Total StockMark into its three components – business, management and price, performing an in-depth analysis of Pani Teresa Medica SA for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.